Press "Enter" to skip to content

Exclusive Report on Companion Diagnostics Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Companion

The “Companion Diagnostics Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Companion Diagnostics industry. The information available in the Companion Diagnostics market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Companion Diagnostics market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Companion Diagnostics Market:

  • Abbott
  • Agilent Technologies Inc.
  • F. Hoffmann
  • La Roche Ltd
  • Biomerieux SA
  • Qiagen NV
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation (Beckman Coulter Inc.)

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999598

    Market Overview:

  • The growth of the global companion diagnostics market can be attributed to the rising focus on personalized medicine and co-development of drug and diagnostic technologies. In addition, rising cases of adverse drug reactions related to drugs, due to the lack of efficacy, drive the need for companion diagnostics. One of the major factors driving the growth of the companion diagnostics market is the increasing demand for personalized medicines and awareness about the same among the population. With companies increasing their collaborations for better biomarkers and diagnostics, in order to focus on cost regulations, there has been significant number of opportunities for its applications in indications, like cancer, cardiovascular and neurological disorders, etc.

    Scope of the Report:

  • Companion diagnostic tests provide information that is essential for the safe and effective use of a corresponding drug or biological product. As per the , the market studied has been segmented by technology, indications, and geography. By technology, the market studied has been further segmented into immunohistochemistry, polymerase chain reaction, in-situ hybridization, real time-polymerase chain reaction, gene sequencing, and other technologies.

    Reasons for Buying Companion Diagnostics Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999598

    Key Market Trends:

    In-situ Hybridization (ISH) Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    In-situ hybridization (ISH), especially fluorescence in-situ hybridization (FISH), is a reliable, reproducible, sensitive, and accurate procedure, which is less affected by tissue fixation and analytical variables, in comparison to immunochemistry and other techniques. It offers the benefit of simultaneous evaluation of morphology and gene amplification. FISH has been the method of choice for use in companion diagnostics for several cancer therapies, such as trastuzumab, lapatinib, and criotinib, which have been already approved by FDA and other therapies, like everolimus, ridaforolimus, bicatulamide, TBD, and other drugs, that are yet to obtain regulatory approval.

    The global market for in-situ hybridization in CDx is growing because of technological advancements, like the recent development of bright-field in-situ hybridization techniques, chromogenic in-situ hybridization (CISH), and the automated silver-enhanced in-situ hybridization (SISH) for the determination of gene status. Thus, considering the aforementioned factors, the ISH segment is expected to exhibit growth over the forecast period.

    North America Captured the Largest Market Share and is Expected to Retain its Dominance

    North America dominated the overall companion diagnostics market, with the United States emerging as the major contributor to the market. The use of companion diagnostics is taking up a central role as an important treatment decision tool for a number of oncology drugs, which is also reflected in the way the FDA classifies these assays in relation to risk. In the United States, companion diagnostic assays are classified as IVD class III products, which represents a high-risk category, and consequently, the highest level of regulatory control. Hence, owing to high healthcare technology adoption rates and increasing demand for personalized medicine, the market for companion diagnostics in the United States is expected to register a substantial growth rate during the forecast period.

    Companion Diagnostics Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999598

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Companion Diagnostics Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Companies Promoting Personalized Medicine and Targeted Therapy as a New Treatment Option
    4.2.2 Increasing Cases of Adverse Drug Reactions
    4.2.3 Co-development of Drug and Diagnostic Technology
    4.3 Market Restraints
    4.3.1 High Cost of Drug Development and Associated Clinical Trials
    4.3.2 Reimbursement Issues among Many Countries
    4.4 Industry Attractiveness- Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Technology
    5.1.1 Immunohistochemistry (IHC)
    5.1.2 Polymerase Chain Reaction (PCR)
    5.1.3 In-situ Hybridization (ISH)
    5.1.4 Real-time PCR (RT-PCR)
    5.1.5 Gene Sequencing
    5.1.6 Other Technologies
    5.2 By Indication
    5.2.1 Lung Cancer
    5.2.2 Breast Cancer
    5.2.3 Colorectal Cancer
    5.2.4 Leukemia
    5.2.5 Melanoma
    5.2.6 Other Indications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 United Kingdom
    5.3.2.2 Germany
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Agilent Technologies Inc.
    6.1.3 F. Hoffmann-La Roche Ltd
    6.1.4 Biomerieux SA
    6.1.5 Qiagen NV
    6.1.6 Siemens Healthcare
    6.1.7 Thermo Fisher Scientific Inc.
    6.1.8 Danaher Corporation (Beckman Coulter Inc.)

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Gene Expression Profiling Industry 2019 Global Market Innovative Technologies, Supply Demand Scenario, Key Solutions, Growth Rate, Future Trends, Industry Vertical, and Region Analysis – Global Forecast to 2026

    Global LASIK Surgery Market 2019 Size & Share, Regional Demand, Future Scope, Challenges, Key Players, Business Development Opportunity and Forecast to 2026,

    Tapioca Pearls Market 2019 | Global Industry Demand, Top Leading Countries by Size, Share, Future Growth Rate, and Investment by Forecast to 2023

    Antacids Market 2019 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2024

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *